RapMed-1504

N/A

Report date: 2022/09/21 17:48:11

Base Information

Drug NameRapMed-1504
Drug Alias NameRapMed-1504
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesRaphas Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRaphas Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A